InsiderTrades

Form 4 for PFE Pfizer

Accepted 2026-02-27 00:00:00 ET · period of report 2026-02-25 · accession 0001225208-26-002821 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-02-27 2026-02-25 PFE SAHNI PAYAL EVP F - Tax $26.92 -55.1K 27.7K -67% -$1.48M
D 2026-02-27 2026-02-25 PFE SAHNI PAYAL EVP M - OptEx $33.82 +56.9K 82.8K +219% +$1.92M
D 2026-02-27 2026-02-25 PFE SAHNI PAYAL EVP M - OptEx $0.00 -56.9K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-25 F D 1,083 $27.09 81,733 D — — (F2) The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
2 Common Common Stock 2026-02-25 F D 54,066 $26.92 27,667 D — — (F3) The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). (F4) Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
3 Common Common Stock 2026-02-25 M A 56,888 $33.82 82,816 D — — (F1) The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
4 Derivative Stock Appreciation Rights 2026-02-25 M D 56,888 $0.00 0 D $33.82 · 2026-02-25 to 2026-02-25 56,888 Common Stock